Pfizer-BioNTech Covid-19 Vaccine, Bivalent

Manufacturer
Pfizer Manufacturing Belgium NV | Pfizer Inc | Pharmacia & Upjohn Company LLC | BioNTech Innovative Manufacturing Services GmbH | BioNTech Manufacturing GmbH | BioNTech Manufacturing Marburg GmbH | Hospira, Inc. | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | Pfizer Ireland Pharmaceuticals
Effective date
2022-10-14
Label type
VACCINE LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 21:51:31

Label at a glance#

ProductPfizer-BioNTech Covid-19 Vaccine, Bivalent
Active ingredientTOZINAMERAN, BNT162B2 OMICRON (BA.4/BA.5)
Label structure1 sections

Label contents#

Full prescribing information#

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image not
available

Principal Display Panel
Principal Display Panel

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59267-0609-1ML - Milliliter59267-060988b520c8-aded-4453-8f2f-5a9fc870e3b012022-11-07
59267-0609-2ML - Milliliter59267-0609312761a9-835f-4e10-ba73-585845df0f6812022-11-07

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
59267-060959267-0609-1, 59267-0609-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.